FdaApplication
ANDA 203843
Identifiers
- fda_app_no: ANDA203843
Properties
| Property | Value |
|---|---|
| applicant_name | CHARTWELL RX SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2024-09-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE | EQ 25MG BASE | TABLET;ORAL |
| ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE | EQ 150MG BASE | TABLET;ORAL |
2 products